slotkoers
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
40,9 CNY | +0,69% | -9,17% | -20,66% |
Vakgebied
Aantal werknemers: 1 961
Verkoop per activiteit
CNY in miljoen | 2021 | Gewicht | 2022 | Gewicht | Delta |
---|---|---|---|---|---|
Drug
98,6
%
| 2 206 | 98,2 % | 2 342 | 98,6 % | +6,19% |
Promotional Services
0,8
%
| 31 | 1,4 % | 19 | 0,8 % | -38,41% |
Factory Rental
0,6
%
| 8 | 0,4 % | 14 | 0,6 % | +72,49% |
Others
0,0
%
| 0 | 0,0 % | 0 | 0,0 % | +10,65% |
Verkoop per regio
CNY in miljoen | 2021 | Gewicht | 2022 | Gewicht | Delta |
---|---|---|---|---|---|
China
100,0
%
| 2 245 | 100,0 % | 2 376 | 100,0 % | +5,82% |
Abroad
0,0
%
| 0 | 0,0 % | 0 | 0,0 % | +12,92% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Jia Tong
CEO | Chief Executive Officer | 46 | 01-01-03 |
Lie Ming Ding
CEO | Chief Executive Officer | 60 | 07-01-03 |
Jian Xun Fan
DFI | Director of Finance/CFO | 52 | 01-01-16 |
Jiang Wan
COO | Chief Operating Officer | 56 | 01-04-11 |
Jia Bing Wang
CTO | Chief Tech/Sci/R&D Officer | 60 | 28-02-16 |
Jian Hao Shen
IRC | Investor Relations Contact | - | - |
Ling Xi Wu
SEC | Corporate Secretary | 41 | 24-09-20 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Lie Ming Ding
CEO | Chief Executive Officer | 60 | 07-01-03 |
Jiang Nan Cai
BRD | Director/Board Member | 67 | 22-11-19 |
Jia Bing Wang
CTO | Chief Tech/Sci/R&D Officer | 60 | 28-02-16 |
Jia Tong
CEO | Chief Executive Officer | 46 | 01-01-03 |
Jiang Wan
COO | Chief Operating Officer | 56 | 01-04-11 |
Yang Nan Zhang
CHM | Chairman | 52 | 22-11-18 |
Fei Wu
BRD | Director/Board Member | 47 | 27-11-17 |
Tian Xu
BRD | Director/Board Member | 62 | 17-10-22 |
Jia Jia Xiao
BRD | Director/Board Member | 41 | 17-10-22 |
Rong Wang
BRD | Director/Board Member | 61 | 27-12-22 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 418 485 885 | 215 716 338 ( 51,55 %) | 0 | 51,55 % |
Participaties
Naam | Aandelen | % | Totale waarde |
---|---|---|---|
C4 THERAPEUTICS, INC. 8.12% | 5 567 928 | 8.12% | 61 135 849 $ |
Bedrijfsgegevens
Betta Pharmaceuticals Co., Ltd.
355 Xingzhong Road Yuhang Economic & Tech Dev Zone
311100, Hangzhou
+
http://www.bettapharma.comSector
Verkoop per activiteit
Verkoop per regio
Herzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
-20,66% | 2,37 mld. | |
+13,53% | 76,83 mld. | |
+13,52% | 9,63 mld. | |
-7,87% | 5,37 mld. | |
+12,50% | 4,28 mld. | |
+18,09% | 3,71 mld. | |
+42,95% | 2,91 mld. | |
-19,01% | 2,54 mld. | |
+17,86% | 1,87 mld. | |
-8,99% | 1,65 mld. |
- Beurs
- Aandelen
- Aandeel Betta Pharmaceuticals Co., Ltd. - Shenzhen S.E.
- Onderneming Betta Pharmaceuticals Co., Ltd.